Reham Hamida

Ms. Reham Hamida

Faculty of Science, Alexandria University, Egypt
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
RHReham Hamida
Reham Hamida
NANabila Elsayed Abdelmeguid
Nabila Elsayed Abdelmeguid
MAMohamed Abdelaal Ali
Mohamed Abdelaal Ali
MBMashael Bin-Meferij
Mashael Bin-Meferij
Mahmoud Ibrahim KahlilMahmoud Ibrahim Kahlil
Mahmoud Ibrahim Kahlil
Background: The emergence of multi drug-resistant (MDR) bacterial infections and cancer has necessitated the development and discovery of alternative eco-safe antibacterial and anticancer agents. Biogenic fabrication of metallic nanoparticles is an emerging discipline for production of nanoproducts that exert potent anticancer and antibacterial activity, and do not suffer from the limitations inherent in physiochemical synthesis methods. Methodology: In this study, we isolated, purified, and characterized a novel cyanobacteria extract (Desertifilum IPPAS B-1220) to utilize in biofabrication of silver nanoparticles (D-SNPs). D-SNPs were produced by adding Desertifilum extract to silver nitrate solution under controlled conditions. Biofabrication of D-SNPs was confirmed using a UV-Vis spectrophotometer. The resultant D-SNPs were characterized using XRD, FTIR, SEM, and TEM. The toxicity of D-SNPs against five pathogenic bacteria and three cancer cell lines (MCF-7, HepG2, and Caco-2) was evaluated. Results: Formation of D-SNPs was indicated by a color change from pale yellow to dark brown. The peak of the surface plasmon resonance of the D-SNPs was at 421 nm. The XRD detected the crystallinity of D-SNPs. FTIR showed that polysaccharides and proteins may have contributed to the biofabrication of D-SNPs. Under SEM and TEM, the D-SNPs were spherical with diameter ranges from 4.5 to 26 nm. The D-SNPs significantly suppressed the growth of five pathogenic bacteria, and exerted cytotoxic effects against MCF-7, HepG2, and Caco-2 cancer cells with IC 50 values of 58, 32, and 90 μg/mL, respectively. Conclusion: These findings showed for the first time the potentiality of novel cyanobacteria strain Desertifilum IPPAS B-1220 to fabricate small SNPs that acted as potent anticancer and antibacterial material against different cancer cell lines and pathogenic bacterial strains. These findings encourage the researchers to focus on cyanobacteria in general and especially Desertifilum sp. IPPAS B-1220 for synthesizing different NPs that opening the window for new applications.

1 August 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
RHReham Hamida
Reham Hamida
MAMohamed Abdelaal Ali
Mohamed Abdelaal Ali
ARAlya Mohammed Othman Redhwan
Alya Mohammed Othman Redhwan
MBMashael Bin-Meferij
Mashael Bin-Meferij
Green synthesis of nanoparticles (NPs) is a global ecofriendly method to develop and produce nanomaterials with unique biological, physical, and chemical properties. Recently, attention has shifted toward biological synthesis, owing to the disadvantages of physical and chemical synthesis, which include toxic yields, time and energy consumption, and high cost. Many natural sources are used in green fabrication processes, including yeasts, plants, fungi, actinomycetes, algae, and cyanobacteria. Cyanobacteria are among the most beneficial natural candidates used in the biosynthesis of NPs, due to their ability to accumulate heavy metals from their environment. They also contain a variety of bioactive compounds, such as pigments and enzymes, that may act as reducing and stabilizing agents. Cyanobacteria-mediated NPs have potential antibacterial, antifungal, antialgal, anticancer, and photocatalytic activities. The present review paper highlights the characteristics and applications in various fields of NPs produced by cyanobacteria-mediated synthesis.

25 May 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
RHReham Hamida
Reham Hamida
MAMohamed Abdelaal Ali
Mohamed Abdelaal Ali
DGDoaa A. Goda
Doaa A. Goda
Mahmoud Ibrahim KahlilMahmoud Ibrahim Kahlil
Mahmoud Ibrahim Kahlil
MAMayasar I. Al-Zaban
Mayasar I. Al-Zaban
Emerging antibiotic-resistant bacteria result in increased mortality and have negative economic impacts. It is necessary to discover new strategies to create alternative antibacterial agents that suppress the bacterial resistance mechanism and limit the spread of serious infectious bacterial diseases. Silver nanoparticles may represent a new medicinal agents as alternative antibiotics affect different bacterial mechanisms such as virulence and resistance. In addition to that of silver nitrate (AgNO3) and ampicillin, for the first time, the inhibitory effect of silver nanoparticles synthesized using Desertifilum sp. (D-SNPs) was evaluated against five pathogenic bacteria using the agar well diffusion method. Also, the influence of D-SNPs and AgNO3 on bacterial antioxidant and metabolic activities was studied. The antibacterial activity of D-SNPs and AgNO3 against methicillin-resistant Staphylococcus aureus (MRSA) strains was studied at the morphological and molecular level. D-SNPs and AgNO3 have the ability to inhibit the growth of the five bacterial strains and resulted in an imbalance in the CAT, GSH, GPx and ATPase levels. MRSA treated with D-SNPs and AgNO3 showed different morphological changes such as apoptotic bodies formation and cell wall damage. Moreover, both caused genotoxicity and denaturation of MRSA cellular proteins. Additionally, TEM micrographs showed the distribution of SNPs synthesized by MRSA. This result shows the ability of MRSA to reduce silver nitrate into silver nanoparticles. These data indicate that D-SNPs may be a significant alternative antibacterial agent against different bacteria, especially MDR bacteria, by targeting the virulence mechanism and biofilm formation, leading to bacterial death.

12 April 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
RHReham Hamida
Reham Hamida
MAMohamed Ali
Mohamed Ali
NANabila Abdelmeguid
Nabila Abdelmeguid
MAMayasar I. Al-Zaban
Mayasar I. Al-Zaban
LINA BAZLINA BAZ
LINA BAZ
MBMashael Bin-Meferij
Mashael Bin-Meferij
Green synthesis of nanoparticles (NPs) is a safe, eco-friendly, and relatively inexpensive alternative to conventional routes of NPs production. These methods require natural resources such as cyanobacteria, algae, plants, fungi, lichens, and naturally extracted biomolecules such as pigments, vitamins, polysaccharides, proteins, and enzymes to reduce bulk materials (the target metal salts) into a nanoscale product. Synthesis of nanomaterials (NMs) using lichen extracts is a promising eco-friendly, simple, low-cost biological synthesis process. Lichens are groups of organisms including multiple types of fungi and algae that live in symbiosis. Until now, the fabrication of NPs using lichens has remained largely unexplored, although the role of lichens as natural factories for synthesizing NPs has been reported. Lichens have a potential reducible activity to fabricate different types of NMs, including metal and metal oxide NPs and bimetallic alloys and nanocomposites. These NPs exhibit promising catalytic and antidiabetic, antioxidant, and antimicrobial activities. To the best of our knowledge, this review provides, for the first time, an overview of the main published studies concerning the use of lichen for nanofabrication and the applications of these NMs in different sectors. Moreover, the possible mechanisms of biosynthesis are discussed, together with the various optimization factors influencing the biological synthesis and toxicity of NPs.

1 January 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RHReham Hamida
Reham Hamida
ASAshwag Shami
Ashwag Shami
MAMohamed Ali
Mohamed Ali
ZAZakiah Nasser Almohawes
Zakiah Nasser Almohawes
AMAfrah Mohammed
Afrah Mohammed
MBMashael Bin-Meferij
Mashael Bin-Meferij
Mode of action of kefir supplementary dietary against viral infection.

1 April 2020 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
RERefaat Eid
Refaat Eid
MBMashael Bin-Meferij
Mashael Bin-Meferij
AEAttalla Farag El-Kott
Attalla Farag El-Kott
SESamy M Eleawa
Samy M Eleawa
MZMohamed Samir Ahmed Zaki
Mohamed Samir Ahmed Zaki
MKMohammad A. Khalil
Mohammad A. Khalil